61.36
price down icon5.69%   -3.70
after-market Handel nachbörslich: 61.36
loading

Finanzdaten der Guardant Health Inc-Aktie (GH)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
14.06%
232.09
203.47 201.81 191.48 177.24
Cost Of Revenue
8.67%
81.20
74.72 - - -
Gross Profit
17.19%
150.88
128.75 - - -
Operating Expenses
7.30%
257.30
239.79 327.78 308.80 277.85
Benefits Costs and Expenses
11.27%
331.95
298.34 312.10 299.20 279.73
Costs And Expenses
7.63%
338.50
314.51 327.78 308.80 277.85
Operating Income/Loss
4.17%
-106.41
-111.04 -125.97 -117.33 -100.62
Income/Loss From Continuing Operations Before Tax
5.26%
-99.86
-94.87 -110.29 -107.72 -102.50
Income Tax Expense/Benefit
86.90%
0.038
0.29 0.716 0.03 0.133
Income/Loss From Continuing Operations After Tax
4.98%
-99.90
-95.16 -111.01 -107.75 -102.63
Net Income/Loss
4.98%
-99.90
-95.16 -111.01 -107.75 -102.63
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.20%
124.11
123.87 0.339 123.05 122.45
Diluted Average Shares
0.20%
124.11
123.87 0.339 123.05 122.45
Basic Earnings Per Share
3.90%
-0.80
-0.77 -0.90 -0.88 -0.84
Diluted Earnings Per Share
3.90%
-0.80
-0.77 -0.90 -0.88 -0.84
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research WAT
$299.69
price up icon 3.32%
diagnostics_research DGX
$180.11
price up icon 0.33%
$166.56
price down icon 0.58%
diagnostics_research LH
$275.23
price up icon 0.51%
diagnostics_research MTD
$1,287.79
price up icon 1.51%
diagnostics_research IQV
$184.08
price down icon 0.29%
Kapitalisierung:     |  Volumen (24h):